Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-486-6 | CAS number: 60-80-0
Endpoint summary
Administrative data
Description of key information
Oral LD50 values ranged from 1250 to 1807 mg/kg bw/day for cats, guinea pigs, mice and rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 1 250 mg/kg bw
Additional information
Non-human data:
Data on acute toxicity of phenazone were available for different species and several LD50 values for acute toxicity after oral application were reported:
In two oral acute toxicity studies with mice LD50 values of 1310 and 1492 mg/kg bw/day were reported.
In two oral acute toxicity studies with rats LD50 values of 1705 and 1807 mg/kg bw/day were reported.
In an oral acute toxicity study with cats a LD50 of 1250 mg/kg bw/day was reported.
In an oral acute toxicity study with guinea pigs a LD50 of 1492 mg/kg bw/day was reported.
General clinical symptoms for acute toxicity in rodents are decrease in motility, incoordination, tonoclonic or tonic spasm. Spasms were reported predominantly after administration of lethal doses. Symptoms of acute toxicity subside after one day. After 2-3 weeks no macroscopic organ damages were detectable.
Data on acute toxicity of phenazone were available for acute toxicity following administration via alternative routes were reported:
In a subcutaneous acute toxicity study with mice a LD50 of 1000 mg/kg bw/day was reported.
In an intraperitoneal acute toxicity study with mice a LD50 of 750 mg/kg bw/day was reported.
In an intravenous acute toxicity study with mice a LD50 of 500 mg/kg bw/day was reported.
Human data:
No data available.
Justification for classification or non-classification
Oral:
Based on Directive 67/548/EEC (DSD) and Regulation 1272/2008/EC (CLP), phenazone was classified as hamful if swallowed ( Xn, R22; cat 4, H302).
Inhalation:
Based on Directive 67/548/EEC (DSD) and Regulation 1272/2008/EC (CLP), phenazone was not classified for acute inhalative toxicity.
Dermal:
Based on Directive 67/548/EEC (DSD) and Regulation 1272/2008/EC (CLP), phenazone was not classified for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
